Latest News

Immunotherapy drug can be effective in treating patients with recurrent brain tumors

A UCLA-led study suggests that for people with recurrent glioblastoma, administering an immunotherapy drug before surgery is more effective than using the drug afterward.

Source link

Related posts

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference


Enhancing scientific dissemination in neuroscience via preprint peer-review: “Peer Community In Circuit Neuroscience”


Research to advance cancer therapy


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy